Boris Y. Kazennyy - Concepedia

Author

Boris Y. Kazennyy

Centers for Disease Control and Prevention

Also Known As

B. Y. Kazennyy, Boris Kazennyy, Boris Y Kazennyy, Boris Y. Kazennyy

Publications

886

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Institute of Quality Tartu University Hospital South African Medical Research Council Tropical Disease Foundation

About

Boris Y. Kazennyy is an author at Centers for Disease Control and Prevention specializing in tuberculosis, drug resistance, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	380
2	Health Sciences	1	1	224
3	Epidemiology	1	1	224
4	Global Health	1	1	224
5	Clinical Epidemiology	1	1	156

Boris Y. Kazennyy

Publications

872

Citations

H-Index

Page 1

	Year	Citations
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study Tracy Dalton, Peter Cegielski, Somsak Akksilp, The Lancet Multidrug-resistant TuberculosisPulmonary TuberculosisPreventive MedicineHealth SciencesGlobal Health	2012	224
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies Ekaterina V. Kurbatova, J. Peter Cegielski, Christian Lienhardt, The Lancet Respiratory Medicine Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis PreventionClinical EpidemiologyTuberculosis	2015	156
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study Aditya Sharma, Andrew Hill, Ekaterina V. Kurbatova, The Lancet Infectious Diseases	2017	151
Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis J. Peter Cegielski, Tracy Dalton, Martín Yagui, Clinical Infectious Diseases	2014	149
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt, Clinical Infectious Diseases	2015	100
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study Courtney M. Yuen, Ekaterina V. Kurbatova, Thelma E. Tupasi, PLoS Medicine	2015	46
Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002–2005 Joseph S. Cavanaugh, Boris Y. Kazennyy, Minh Ly Nguyen, The International Journal of Tuberculosis and Lung Disease	2012	33
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries Ekaterina V. Kurbatova, Tracy Dalton, Julia Ershova, Emerging infectious diseases	2015	13

Page 1